Skip to main content

News and blog posts

29
Sep 2020

King’s Fund report on transformative technology for long-term health conditions in the UK and Nordic countries

On August 03, 2020, King’s Fund issued a report on technology and innovation for long-term health conditions. It was commissioned by Academic Health Science Networks (AHSNs) in England to explore four different digital innovations in health services from the UK and the Nordic countries to demonstrate transformative potential and compare and contrast themes across geographies.
28
Sep 2020

Favorable opinion from HAS about innovation package (forfait innovation) for the detection of the SARS-CoV-2 by saliva tests

At the beginning of August 2020, the French National Authority for Health (HAS) issued a favorable opinion on the inclusion of the genome detection of SARS-CoV-2 by gene amplification on saliva samples to the innovation package (forfait innovation) according to the article L. 165-1-1 of the social security code. The package is approved by the Ministry of Solidarity and Health, after consultation with HAS.
23
Sep 2020

Multiple endoscopy-related procedure codes to be released in Germany in 2021

In mid-August 2020, the German Federal Institute for Drugs and Medical Devices (BfArM) published the preliminary 2021 version of OPS procedure coding nomenclature. Numerous content updates and new procedure codes inclusion concern the chapters 1 “Diagnostic measures,” 5 “Operations,” and 8 “Non-operative therapeutic measures.” The list of new endoscopy-related procedure codes added under the respective OPS sub-chapters of chapters 1 and 5 is provided below:
22
Sep 2020

Research project to analyze factors besides clinical evidence, influencing reimbursement decisions or the hospital benefit catalog 2010-2020, started in Austria

Earlier in September 2020, the Austrian Institute for Health Technology Assessment (AIHTA) released a synopsis of the ongoing research project “Reimbursement decisions for medical procedures in Austria: An analysis of factors – besides clinical evidence – influencing reimbursement decisions for the hospital benefit catalog 2010-2020.”